News 1/10/25 – HIStalk
Top News
Transcarent, which offers employee healthcare benefits navigation services, acquires rival Accolade for $621 million in cash.
ACCD shares have lost 78% in the past 12 months and are down 90% since the company’s…
Tag: IPO
IPO vs. Acquisition for Life Science Companies: Expert Q&A
Taylor Wirth, Partner at Barnes & Thornburg
Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they pursue an initial public offering (IPO) to fuel their growth,…
Continue Reading
Monday Morning Update 11/4/24 – HIStalk
Top News
Maven Clinic, which offers virtual women’s and family health services, reportedly lays off 10% of its headcount weeks after it raised a $125 million Series F funding round at a $1.7 billion valuation.
Employees…
News 10/4/24 – HIStalk
Top News
Virtual care chronic disease management vendor Omada Health files SEC paperwork for an IPO that is planned for early 2025.
The 13-year-old company has raised $450 million. It was valued at $1 billion in…
Brutally Honest Interview about Digital Health with Sergei Polevikov
Welcome to a new episode of Digital Health Interviews!Today, we dive into a brutally honest discussion about digital health with our guest, Sergei Polevikov. Sergei brings a wealth of experience and unfiltered insights into…
Continue Reading
Navigating the Tricky Climate of Health Tech Funding – MedCity News
The health tech space is rapidly evolving, and the climate for funding remains tricky at best. For organizations on the hunt for capital, how and where you share your story can be a make-or-break…
Continue Reading
News 5/31/24 – HIStalk
Top News
Waystar targets a valuation of nearly $4 billion in its upcoming IPO.
The company, which was formed in early 2018 by the merger of Navicure and ZirMed, was valued at $2.7 billion in…
Tempus AI Files for IPO, Eyes Over $600M in Funding for AI-Powered Precision Medicine
What You Should Know:
– Tempus AI, a leader in artificial intelligence (AI)-powered precision medicine, filed with the Securities and Exchange Commission (SEC) on Monday to raise up to $100M in an initial public offering…
Continue Reading
Glen Tullman Has ‘No Interest’ In Selling Transcarent, But IPO Is a Possibility – MedCity News
After care navigation company Transcarent announced last week that it raised $126 million in Series D funding, CEO Glen Tullman told MedCity News that he has “no interest” in selling the company. However, an…
Continue Reading
Define Ventures Appoints Frank Williams as Venture Partner
Frank Williams, Venture Partner at Define Ventures
What You Should Know:
– Define Ventures, the leading early-stage investor in digital health companies, announced today the appointment of Frank Williams as Venture Partner.
– Williams, a seasoned entrepreneur…
Continue Reading